Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | ENTBF |
---|---|---|
09:32 ET | 100 | 0.07 |
03:08 ET | 1000 | 0.09 |
03:50 ET | 487 | 0.092 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Entheon Biomedical Corp | 1.2M | --- | --- |
Entheon Biomedical Corp. is a Canada-based biotechnology research and development company. The Company is interested in treating addiction and substance-use disorders.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2M |
---|---|
Revenue (TTM) | $0.00 |
Shares Outstanding | 8.9M |
Entheon Biomedical Corp does not pay a dividend. | |
Beta | 1.65 |
EPS | $-0.05 |
Book Value | $0.05 |
P/E Ratio | --- |
Price/Sales (TTM) | --- |
Price/Cash Flow (TTM) | --- |
Operating Margin | --- |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.